Emcure Pharmaceuticals Ltd (EMCURE) — Capital Reinvestment Ratio
Emcure Pharmaceuticals Ltd (EMCURE) has a Capital Reinvestment Ratio of 0.50x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs2.56 Billion) in capital expenditures (Rs1.29 Billion). Check tangible net worth ratio of Emcure Pharmaceuticals Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Emcure Pharmaceuticals Ltd Capital Reinvestment Ratio (2022–2026)
This chart tracks Emcure Pharmaceuticals Ltd's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see how efficiently does Emcure Pharmaceuticals Ltd generate cash.
Annual Capital Reinvestment Ratio for Emcure Pharmaceuticals Ltd (2022–2026)
Year-by-year Capital Reinvestment Ratio for Emcure Pharmaceuticals Ltd from 2022 to 2026. See cash generation quality of Emcure Pharmaceuticals Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.42x | Rs8.51 Billion | Rs3.61 Billion | ▼ -11.3% |
| 2025 | 0.48x | Rs8.52 Billion | Rs4.07 Billion | ▲ +70.7% |
| 2024 | 0.28x | Rs10.97 Billion | Rs3.07 Billion | ▼ -48.2% |
| 2023 | 0.54x | Rs7.47 Billion | Rs4.03 Billion | ▲ +4.5% |
| 2022 | 0.52x | Rs7.68 Billion | Rs3.97 Billion | — |